Cargando…

Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate

Detalles Bibliográficos
Autores principales: Dickinson, P D, Peel, D N Y, Sundar, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326681/
https://www.ncbi.nlm.nih.gov/pubmed/22415241
http://dx.doi.org/10.1038/bjc.2012.78
_version_ 1782229547324801024
author Dickinson, P D
Peel, D N Y
Sundar, S
author_facet Dickinson, P D
Peel, D N Y
Sundar, S
author_sort Dickinson, P D
collection PubMed
description
format Online
Article
Text
id pubmed-3326681
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-33266812013-04-10 Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate Dickinson, P D Peel, D N Y Sundar, S Br J Cancer Letter to the Editor Nature Publishing Group 2012-04-10 2012-03-13 /pmc/articles/PMC3326681/ /pubmed/22415241 http://dx.doi.org/10.1038/bjc.2012.78 Text en Copyright © 2012 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Dickinson, P D
Peel, D N Y
Sundar, S
Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
title Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
title_full Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
title_fullStr Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
title_full_unstemmed Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
title_short Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
title_sort metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326681/
https://www.ncbi.nlm.nih.gov/pubmed/22415241
http://dx.doi.org/10.1038/bjc.2012.78
work_keys_str_mv AT dickinsonpd metronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate
AT peeldny metronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate
AT sundars metronomicchemotherapywithcyclophosphamideanddexamethasoneinpatientswithmetastaticcarcinomaoftheprostate